{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T06:22:26Z","timestamp":1775197346651,"version":"3.50.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T00:00:00Z","timestamp":1233446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T00:00:00Z","timestamp":1233446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2009,2]]},"DOI":"10.1016\/j.cgh.2008.10.024","type":"journal-article","created":{"date-parts":[[2008,10,31]],"date-time":"2008-10-31T04:11:44Z","timestamp":1225426304000},"page":"145-148","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":96,"title":["Efficient Identification and Evaluation of Effective Helicobacter pylori Therapies"],"prefix":"10.1016","volume":"7","author":[{"given":"David Y.","family":"Graham","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2008.10.024_bib1","series-title":"Sleisenger & Fordtran's gastrointestinal and liver disease","first-page":"1049","article-title":"Helicobacter pylori","author":"Graham","year":"2006"},{"key":"10.1016\/j.cgh.2008.10.024_bib2","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/aje\/kwj018","article-title":"Iron deficiency and Helicobacter pylori infection in the United States","volume":"163","author":"Cardenas","year":"2006","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.cgh.2008.10.024_bib3","doi-asserted-by":"crossref","first-page":"7078","DOI":"10.3748\/wjg.v11.i45.7078","article-title":"Vitamin B12 deficiency and gastric histopathology in older patients","volume":"11","author":"Dholakia","year":"2005","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.cgh.2008.10.024_bib4","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1572-0241.2005.30252.x","article-title":"Iron-deficiency anemia and Helicobacter pylori infection: a review of the evidence","volume":"100","author":"DuBois","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2008.10.024_bib5","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.beha.2004.10.002","article-title":"Gastropathic sideropenia","volume":"18","author":"Hershko","year":"2005","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1016\/j.cgh.2008.10.024_bib6","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1523-5378.2007.00518.x","article-title":"A report card to grade Helicobacter pylori therapy","volume":"12","author":"Graham","year":"2007","journal-title":"Helicobacter"},{"key":"10.1016\/j.cgh.2008.10.024_bib7","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1365-2036.2007.03386.x","article-title":"Meta-analysis: the effect of antibiotic resistance status on the efficacy of triple and quadruple first-line therapies for Helicobacter pylori","volume":"26","author":"Fischbach","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2008.10.024_bib8","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1111\/j.1572-0241.2007.01393.x","article-title":"American College of Gastroenterology guideline on the management of Helicobacter pylori infection","volume":"102","author":"Chey","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2008.10.024_bib9","doi-asserted-by":"crossref","first-page":"923","DOI":"10.7326\/0003-4819-148-12-200806170-00226","article-title":"Meta-analysis: sequential therapy appears superior to standard therapy for Helicobacter pylori infection in patients naive to treatment","volume":"148","author":"Jafri","year":"2008","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cgh.2008.10.024_bib10","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/ncpgasthep1138","article-title":"New concepts of resistance in the treatment of Helicobacter pylori infections","volume":"5","author":"Graham","year":"2008","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2008.10.024_bib11","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/sj.clpt.6100043","article-title":"Pharmacogenomics-based tailored versus standard therapeutic regimen for eradication of H. pylori","volume":"81","author":"Furuta","year":"2007","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.cgh.2008.10.024_bib12","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1517\/14656566.8.3.329","article-title":"Treatment and dosing of Helicobacter pylori infection: when pharmacology meets clinic","volume":"8","author":"Treiber","year":"2007","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.cgh.2008.10.024_bib13","doi-asserted-by":"crossref","first-page":"243","DOI":"10.2165\/00003088-200038030-00004","article-title":"Pharmacokinetic considerations in the eradication of Helicobacter pylori","volume":"38","author":"Klotz","year":"2000","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.cgh.2008.10.024_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(89)90015-9","article-title":"Optimal two-stage designs for phase II clinical trials","volume":"10","author":"Simon","year":"1989","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.cgh.2008.10.024_bib15","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1002\/sim.4780131704","article-title":"An optimal three-stage design for phase II clinical trials","volume":"13","author":"Ensign","year":"1994","journal-title":"Stat Med"},{"key":"10.1016\/j.cgh.2008.10.024_bib16","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1002\/(SICI)1097-0258(19971215)16:23<2701::AID-SIM704>3.0.CO;2-1","article-title":"Optimal three-stage designs for phase II cancer clinical trials","volume":"16","author":"Chen","year":"1997","journal-title":"Stat Med"},{"key":"10.1016\/j.cgh.2008.10.024_bib17","series-title":"Design and analysis of clinical trials: concepts and methodologies","author":"Chow","year":"2004"},{"key":"10.1016\/j.cgh.2008.10.024_bib18","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2307\/2530297","article-title":"One-sample multiple testing procedure for phase II clinical trials","volume":"38","author":"Fleming","year":"1982","journal-title":"Biometrics"},{"key":"10.1016\/j.cgh.2008.10.024_bib19","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/j.1572-0241.2006.00637.x","article-title":"Levofloxacin-based triple therapy versus bismuth-based quadruple therapy for persistent Helicobacter pylori infection: a meta-analysis","volume":"101","author":"Saad","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2008.10.024_bib20","series-title":"Helicobacter pylori infection","first-page":"170","article-title":"Conceptual evolution from gastritis, to peptic ulcer and gastritis, to \u2018cystitis of the stomach\u2019 and finally, to a smallpox equivalent","author":"Graham","year":"1993"},{"key":"10.1016\/j.cgh.2008.10.024_bib21","unstructured":"Food and Drug Administration, Department of Health and Human Services Part 50\u2014Protection Of Human Subjects (21 CFR part 50). Available: http:\/\/www.access.gpo.gov\/nara\/cfr\/waisidx_02\/21cfr50_02.html."},{"key":"10.1016\/j.cgh.2008.10.024_bib22","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/S0140-6736(07)61455-X","article-title":"Sequential regimens for Helicobacter pylori eradication","volume":"370","author":"Moayyedi","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.cgh.2008.10.024_bib23","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1136\/gut.2007.125658","article-title":"The sequential therapy regimen for Helicobacter pylori eradication: a pooled-data analysis","volume":"56","author":"Zullo","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2008.10.024_bib24","doi-asserted-by":"crossref","first-page":"725","DOI":"10.2165\/00003495-200868060-00001","article-title":"Therapy for Helicobacter pylori infection can be improved: sequential therapy and beyond","volume":"68","author":"Graham","year":"2008","journal-title":"Drugs"},{"key":"10.1016\/j.cgh.2008.10.024_bib25","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1046\/j.1523-5378.2000.00030.x","article-title":"The HOMER study: the effect of increasing the dose of metronidazole when given with omeprazole and amoxicillin to cure Helicobacter pylori infection","volume":"5","author":"Bardhan","year":"2000","journal-title":"Helicobacter"},{"key":"10.1016\/j.cgh.2008.10.024_bib26","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1097\/00042737-199907000-00002","article-title":"Bismuth triple therapy: still a very important drug regimen for curing Helicobacter pylori infection","volume":"11","author":"de Boer","year":"1999","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2008.10.024_bib27","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1136\/gut.2006.118109","article-title":"One- or two-week triple therapy for Helicobacter pylori: questions of efficacy and inclusion of a dual therapy treatment arm","volume":"56","author":"Graham","year":"2007","journal-title":"Gut"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356508011063?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356508011063?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:03:12Z","timestamp":1761541392000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356508011063"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["S1542356508011063"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2008.10.024","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2009,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficient Identification and Evaluation of Effective Helicobacter pylori Therapies","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2008.10.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 AGA Institute. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}